Neuropsychological and Behavioral Testing in Younger Patients With Cancer
This research trial studies neuropsychological (learning, remembering or thinking) and behavioral outcomes in children and adolescents with cancer by collecting information over time from a series of tests.
Stanford is currently accepting patients for this trial.
Children's Oncology Group
Collaborator: National Cancer Institute (NCI)
- Procedure: Cognitive Assessment
- Other: Quality-of-Life Assessment
- The patient must be currently be enrolled or plan to be enrolled on a COG therapeutic
study that aims to examine neuropsychological, social, emotional, and/or behavioral
- The patient must have receptive and expressive language skills in English, French, or
Spanish; if a patient meets these criteria but the parent/guardian speaks a language
other than English, French, or Spanish, the patient may still be enrolled and tested,
and the parent-report measures should be omitted
- All patients and/or their parents or legal guardians must sign a written informed
- All institutional, Food and Drug Administration (FDA), and National Cancer Institute
(NCI) requirements for human studies must be met
- Patients with a history of moderate to profound intellectual disability (i.e.
intelligence quotient [IQ] =< 55) are not eligible for enrollment; PLEASE NOTE:
Children with a prior history of attention deficit hyperactivity disorder (ADHD) or a
specific learning disability (e.g. dyslexia) are eligible for this study
Ages Eligible for Study
1 Month - N/A
Genders Eligible for Study